Mallinckrodt PLC, an Irish pharmaceutical company with a big footprint and long history in the St. Louis area, will buy U.S.

AlphaQuest LLC reduced its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 35.9% in the ...

Competitive Epinephrine Active Pharmaceutical Ingredient Process, Drug Master File Successfully FiledRichmond, Virginia, March 17, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based certified B ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...

AstraZeneca has signed two deals worth $1.35 billion with Alteogen to develop subcutaneous versions of the British pharma’s ...

Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM)Lifecore ...

The new $5.3 billion deal with the Swiss pharma giant gives Zealand a significant partner to advance its amylin analog obesity shot and create a new combination product.

Hamilton Beach Brands sees revenue growth to $654.7M in 2024, bolstered by acquisitions and cost cuts. Read why HBB stock ...

Fintel reports that on March 17, 2025, D. Boral Capital initiated coverage of Plus Therapeutics (NasdaqCM:PSTV) with a Buy recommendation. Analyst Price Forecast Suggests 1,440.22% Upside As of March ...

Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...